Wednesday, April 12, 2006


Hepatitis C - Ways You Can Get Infected With Hepatitis C(NC)-Hepatitis

Ways You Can Get Infected With Hepatitis C

(NC)-Hepatitis C is spread through contact with infected blood. Here are just some of the ways in which you can be infected with this virus:

Sharing needles, straws, pipes, spoons and other drug-related equipment.

(At least two-thirds of all new hepatitis C infections are drug-use related. Cleaning equipment with bleach does not always effectively kill the virus) p>

Getting a tattoo, body piercing or acupuncture from an operator who does not use sterile equipment or techniques

Being born to a mother with hepatitis C

Getting pierced by a needle or sharp equipment that has infected blood on it ( in a hospital, workplace situation, etc.) p>

People who had blood transfusions before the testing of blood donations became mandatory in 1990 may also be at risk. And, while the risk is low, it is also possible to become infected by sharing personal household articles such as a razor or toothbrush with an infected person. The risk of transmission of hepatitis C during sex is also low, unless both parties have open bleeding sores.

It is estimated that 240, 000 people in Canada are currently infected with hepatitis C, of whom only 30% know they have the virus.

If you think you may be at risk, either now or from past risky activities see a doctor. The virus can be detected with a simple blood test, and there are steps and medications you can take to successfully minimize the effects of the disease if your diagnosis is positive. For more information, visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.



Hepatitis C - Preventing Hepatitis C


Preventing Hepatitis C
Pakistan News Service - ISLAMABAD: Almost four million Americans have hepatitis C, a liver disease caused by the hepatitis C virus (HCV). HCV is spread by sexual contact with an infected person or more often, by direct contact with that person s blood. The New York State

Ashok Leyland FY06 sales up 12%; March sales up 15%
Zee News - New Delhi, Apr 10: Commercial vehicles major Ashok Leyland today reported a 12.5 per cent increase in sales in the year ended March 31, 2006, at 61,626 units (including exports) against 54,740 units in the previous year. Sales in the domestic market

U.S. to deploy non-nuclear deterrents
World Peace Herald - WASHINGTON -- U.S. Strategic Command wants to deploy conventional weapons on Trident submarines within two years, the four-star general in charge of U.S. nuclear forces said. The conversion of some nuclear missiles to precision-guided conventional

Anadys Pharmaceuticals Appoints Robert Schooley, M.D., to its Clinical
Genetic Engineering News - SAN DIEGO , April 10 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced today that it has appointed Robert "Chip" Schooley, M.D., to its Clinical and Scientific Advisory Board. "We are very fortunate to have someone of Dr

Similarities and differences in outcomes of cirrhosis due to
News-Medical.Net - Cirrhosis related to non-alcoholic steatohepatitis (NASH) is associated with fewer complications and a lower mortality compared to cirrhosis from hepatitis C, despite NASH patients' greater risk of dying from cardiovascular events. These findings are

AP Update at 5:58 a.m. EDT
Mojave Daily News - While many people have heard of Hepatitis A and B, not everyone is familiar with Hepatitis C. While types A and B have vaccines, there is no vaccine for type C. According to the Centers for Disease Control, Hepatitis C has now reached epidemic

Tata Motors total vehicle sales up 13.7 in FY-06
New Kerala - Mumbai: Tata Motors today reported a 13.7 per cent increase in total vehicle sales for the fiscal ended March 31, as compared to the previous fiscal. The company sold 4,54,345 units of vehicles (including exports) in FY-06 as against 3,99,566

Tuesday, April 11, 2006


Hepatitis C - Vaccination Tames Hepatitis A Infection


Vaccination Tames Hepatitis A Infection
Title: Vaccination Tames Hepatitis A InfectionCategory: Health NewsCreated: 7/13/2005 1:58:00 AMLast Editorial Review: 7/13/2005 1:58:14 AM

Vitamins Suggested During Combination Therapy
A Japanese research study demonstrates benefits of Vitamin E and C supplementation during combination therapy. These vitamins appear to protect cells from damage typically incurred from conventional Hepatitis C therapy....

A Breakthrough Discovery for Hepatitis C
The state of Florida has recently produced a study illuminating the replication and mutation of the Hepatitis C virus. This kind of progress represents a giant leap forward in tracking this persistent virus, which likely means more accurate and efficient...

Fatty Liver
Title: Fatty LiverCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 8/29/2005

Liver Blood Tests
Title: Liver Blood TestsCategory: Procedures and TestsCreated: 6/2/1998Last Editorial Review: 8/27/2005

Monday, April 10, 2006


Interferon - Hepatitis C Treatment Eligibility and Outcomes Among Patients With ...


Hepatitis C Treatment Eligibility and Outcomes Among Patients With ...
Psychiatric Services (subscription) - Apr 8, 2006... Text]. El-Serag HB, Kunik M, Richardson P, et al: Psychiatric disorders among veterans with hepatitis C infection. Gastroenterology ...

hepatitis C vaccine
News 8 Austin, TX - 7 hours ago... acute infection. Researchers are testing a vaccine for the first time in humans that could prevent hepatitis C infection. The enzymes ...

Peregrine Pharmaceuticals Adopts Stockholder Rights Agreement
Yahoo! News (press release) - Mar 17, 2006... "Our recently announced positive human safety data for Tarvacin in the treatment of hepatitis C infection and increasing evidence of the broad potential of ...

Idenix Announces Licensing of Valopicitabine (NM283) by Novartis
Boursorama, France - Mar 28, 2006... As the prevalence of severe liver disease attributable to hepatitis C rises, deaths due to complications from hepatitis C infection, currently 8,000 to 10,000 ...

Talc Retinopathy
New England Journal of Medicine (subscription), MA - Mar 22, 2006... A recent liver biopsy for the evaluation of the patient's hepatitis C infection showed abundant talc particles under polarized light (Panel C). The hepatic ...

Cirrhosis Patients With Liver Nodules Have Greatly Increased Risk ...
eMaxHealth.com, NC - Mar 9, 2006... to liver tissue. In the United States, cirrhosis is caused most often by hepatitis C infection or alcohol abuse. Since no prior ...

PegInterferon - Peregrine Pharmaceuticals Files Shelf Registration Statement


Peregrine Pharmaceuticals Files Shelf Registration Statement
International News Service, Australia - Mar 31, 2006... In February, Peregrine successfully completed enrollment in a Tarvacin Phase l clinical trial for the treatment of chronic hepatitis C virus infection ...

Novartis Announces in-licensing of Valopicitabine (NM283), a Novel ...
PharmaLive.com (press release), PA - Mar 29, 2006... synergistic with valopicitabine, and this combination could become the first oral combination therapy available for the treatment of chronic hepatitis C. ...

Novelos Therapeutics Files SPA with FDA for Phase 3 Development in ...
Genetic Engineering News, NY - Mar 8, 2006... antiviral activity. Novelos plans to initiate a US-based NOV-205 clinical trial for chronic hepatitis C by mid-2006. Both compounds ...

Human Genome Sciences Reports Positive Interim Results of Phase 2 ...
Yahoo! News (press release) - Mar 14, 2006... safety, tolerability and efficacy of Albuferon(TM) (albumin-interferon alpha 2b) in combination with ribavirin in patients with chronic hepatitis C who failed ...

ViRexx Announces Collaboration with Defence Research and ...
CCNMatthews (press release), Canada - Mar 31, 2006... The Company is also conducting preclinical studies on Chimigen TM therapeutic vaccine candidates to treat chronic hepatitis C infections. ...

Novelos seeks permission to test hepatitis drug in US
Pharmaceutical Business Review - Mar 24, 2006Biotech firm Novelos Therapeutics has filed an investigational new drug application with the FDA for its experimental chronic hepatitis C treatment, NOV-205. ...

MIGENIX Reports Third Quarter Fiscal Year 2006 Results
MSN Money - Mar 8, 2006... development programs, with two phase II clinical outcomes expected this year in our MX-3253 program for the treatment of chronic hepatitis C virus infections ...

Sunday, April 09, 2006


Hepatitis C - SCYNEXIS Announces New Board Chairman and New Board Member


SCYNEXIS Announces New Board Chairman and New Board Member
dBusinessNews.com - Triangle - RESEARCH TRIANGLE PARK -- SCYNEXIS, Inc., a chemistry-focused drug discovery and development company, today announced that Dr. Pamela Kirby has been selected as the new Chairman of the Company's Board of Directors replacing Mr. Philip

BHIVA: HIV/HCV coinfected may have worse survival as they spend less
Aidsmap - HIV-positive individuals who are coinfected with the hepatitis C virus appear to have slightly worse survival than patients who are only infected with HIV, according to data from a study involving HIV-positive patients taking antiretroviral

Relative Risks Of Cirrhosis From Non-alcoholic Steatohepatitis
Medical News Today - Cirrhosis related to non-alcoholic steatohepatitis (NASH) is associated with fewer complications and a lower mortality compared to cirrhosis from hepatitis C, despite NASH patients' greater risk of dying from cardiovascular events. These findings are

Antibodies Neutralizing Peginterferon Alfa during Retreatment of
New England Journal of Medicine - To the Editor: Peginterferons are widely used to treat chronic hepatitis C virus (HCV) infection, an important cause of liver cirrhosis and hepatocellular carcinoma. 1 , 2 , 3 , 4 We describe a patient who did not have a virologic response to

Activists: Hepatitis C clinical trial unfairly excludes blacks
Advocate - Two advocacy groups are blasting the decision by pharmaceutical company Schering-Plough to exclude African-Americans from a clinical trial of its experimental hepatitis C treatment, a decision the company says was needed to better gauge the efficacy

Tata may make Rs 1 lakh car in Jamshedpur
Financial Express - JAMSHEDPUR, MARCH 28: Tata Motors may choose to produce its Rs 1 lakh car in Jamshedpur. It is at a preliminary stage. They have their expansion plan for Jamshedpur. We are discussing that (Rs 1 lakh car project), said a senior bureaucrat from

Novartis Seen 'Saving Face' With Idenix Hep C Deal
Forbes - Friedman, Billings, Ramsey reiterated an "outperform" rating on Idenix Pharmaceuticals after Swiss pharmaceutical titan Novartis exercised an option to co-develop the biotech firm's lead drug candidate. Novartis (nyse: NVS - news - people ) will pay

Interferon - A Breakthrough Discovery for Hepatitis C


A Breakthrough Discovery for Hepatitis C
The state of Florida has recently produced a study illuminating the replication and mutation of the Hepatitis C virus. This kind of progress represents a giant leap forward in tracking this persistent virus, which likely means more accurate and efficient...

Two Studies Recruiting HCV Patients
Sho-saiko-to is the number one liver remedy in Japan. It has been prescribed to over 1.5 million patients (in Japan, doctors medically prescribe certain natural remedies, just like doctors prescribe pharmaceutical drugs in the U.S.). Based on the large body...

Ability to Culture Hepatitis C Virus Leads to Research Advancements
By overcoming the difficulties of culturing live HCV, scientists are now capable of studying the virus more closely. We anticipate this progress will open the door to hepatitis C treatment and prevention....

Cirrhosis Of The Liver
Title: Cirrhosis Of The LiverCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 12/1/2005

Newer Hepatitis B Drug Bests Standard Treatment
Title: Newer Hepatitis B Drug Bests Standard TreatmentCategory: Health NewsCreated: 3/9/2006 1:58:00 AMLast Editorial Review: 3/9/2006 1:58:03 AM

Hepatitis C - Article | Hepatitis C Infection: a Clinical Review.


Article | Hepatitis C Infection: a Clinical Review.
Price: $9.95 | Excerpt: "Abstract: Nearly three million persons in the United States are viremic with hepatitis C (HCV). Despite a decreasing incidence of HCV in this country, the prevalence of..."

Hepatitis C
Hepatitis C. Introduction. Hepatitis C. It's a virus that many of us know little about. It has been called the "silent killer" with good reason. ... Describe the diagnostic tests for Hepatitis C infection. 2. Describe the signs of Hepatitis C infection. 3. List the medications used to ...

Child Health Resources | Children's Hospital & Regional Medical Center
Explore Children's health information and resources. ... Children with hepatitis C infection need to be monitored ... in some patients; however, many patients relapse after the drug is stopped, and the hepatitis C infection comes back ...

Hepatitis C (Advanced)
... for HCV RNA is a reliable way of demonstrating that hepatitis C infection is present and is the most specific test for ...

Hepatitis C CHOICE For Geisinger System Services
Health and wellness services, medical information, and interactive health features for our user community. ... Chronic hepatitis C infection may cause some of the above symptoms, as well as ... Serious complications of hepatitis C infection include ...

OSAP
... Management of Hepatitis C Infection in the HIV-Infected Patient ... Treatment of hepatitis C infection currently consists of interferon taken alone or in combination with ribavirin ...